Outpatient infusion therapy offers promising alternative for pediatric status migrainosus - Children's National

Children with status migrainosus often have few options when migraine symptoms persist despite home treatments, frequently leading to an emergency department (ED) visit. New research led by Elizabeth Pickup, MD, child neurologist at Children's National, suggests that outpatient infusion therapy may provide an effective, patient-centered alternative for children and adolescents experiencing prolonged migraine attacks.

The study, published in the Journal of Child Neurology, evaluated outcomes among 19 pediatric patients with status migrainosus treated through the Children's National Headache Program using a standardized outpatient infusion protocol that included intravenous fluids, ketorolac and an antiemetic, with valproic acid added when needed. Researchers found that all patients experienced meaningful pain relief, with pain scores decreasing by an average of 4.3 points on a 10-point scale. Treatment was also associated with significant reductions in photophobia and phonophobia, suggesting that outpatient infusion therapy may offer an effective alternative to ED care for children experiencing prolonged migraine attacks.

Why it matters

Migraine is one of the most common neurologic disorders in children and adolescents, and status migrainosus can be particularly debilitating. Lasting 72 hours or longer, these severe migraine attacks are often resistant to standard rescue medications and can interfere with school attendance, social activities and quality of life. Patients frequently seek care in EDs, where treatment approaches vary and the clinical environment itself may worsen symptoms.

"Most evidence supporting outpatient infusion centers for status migrainosus comes from adult populations," Dr. Pickup said. "There has been a lack of pediatric-specific data, so clinicians have lacked the evidence base to confidently offer an emergency department alternative to this population."

Meaningful symptom improvement

Researchers prospectively followed patients treated through outpatient infusions, collecting patient-reported outcomes before and after treatment. The median headache duration prior to infusion was 11 days, and patients had missed a median of four school days in the week before receiving therapy.

Following infusion, all 19 patients reported lower pain scores, and every patient achieved their personal pain-reduction goal. The study also demonstrated significant improvements in light sensitivity and sound sensitivity, symptoms that often contribute substantially to migraine-related disability.

"What is most exciting is that every single patient improved," Dr. Pickup said. "All 19 children with status migrainosus had reduced pain intensity after outpatient infusion, with a mean reduction of 4.3 points on a 0-10 scale, a clinically meaningful drop."

Patient satisfaction was similarly encouraging. Although follow-up survey participation was limited, all respondents reported they would consider outpatient infusion therapy again for future migraine episodes.

Children's National advances pediatric headache care

The study highlights the Children's National Headache Program's commitment to developing evidence-based approaches that address the unique needs of children and adolescents with complex headache disorders.

According to Dr. Pickup, the research represents one of the first prospective, single-center evaluations of a structured outpatient infusion protocol specifically for pediatric status migrainosus.

"By operationalizing and evaluating this model in children, and demonstrating both symptom relief and patient willingness to return to it, the group is helping define an evidence-based care pathway for a population where such data have been lacking," she said.

As pediatric headache specialists continue to seek effective strategies for acute migraine management, the findings provide additional evidence that outpatient infusion therapy may offer a safe, effective and patient-preferred alternative to emergency care. Future studies comparing outpatient and ED treatment pathways could further clarify the role of infusion therapy in reducing healthcare utilization while improving the patient experience.

Additional Children's National authors include Alexandra B. Kornbluh, MD, Mrinmayee Takle, MD, Alexandra Wood, MD, Raquel Langdon, MD, Marc DiSabella, DO, Jeffrey Strelzik, MD.

Read the full study, Outpatient Infusion Therapy for Pediatric Status Migrainosus: Real World Clinical Outcomes from a Tertiary Care Center, in the Journal of Child Neurology.